Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
740
45
ARF
40
RHD
35
Patients, n
30
25
20
15
10
5
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
1999
2000
1998
1997
1996
1995
1994
1993
Year
1.2
1
0.8
0.6
0.4
0.2
0
1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
Year
Fig. 2. Cause-specific mortality rate due to RHD in the SA population, 19972012. (Dotted lines = the confidence intervals of the estimates of mortality.)
GUEST EDITORIAL
741
5. Robertson KA, Volmink JA, Mayosi BM. Towards a uniform plan for the control of rheumatic fever
and rheumatic heart disease in Africa the Awareness Surveillance Advocacy Prevention (A.S.A.P.)
Programme. S Afr Med J 2006;96(3):241-245.
6. Mayosi BM, Gamra H, Dangou J-M, Kasonde J. Rheumatic heart disease in Africa: The
Mosi-o-Tunya call to action. Lancet Glob Health 2014;2(8):e438-e439. DOI:10.1016/S2214109X(14)70234-7
7. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of
newly diagnosed rheumatic heart disease in urban African adults: Insights from the Heart of Soweto
Study. Eur Heart J 2010;31(6):719-727. DOI:10.1093/eurheartj/ehp530
8. Zhlke LJ, Engel ME, Watkins D, Mayosi BM. Incidence, prevalence and outcome of rheumatic heart
disease in South Africa: A systematic review of contemporary studies. Int J Cardiol 2015;199:375-383.
DOI:10.1016/j.ijcard.2015.06.145
9. Mayosi BM, Benatar SR. Health and health care in South Africa 20 years after Mandela. N Engl J Med
2014;371(14):1344-1353. DOI:10.1056/NEJMsr1405012
10. Shung-King M, Engel ME, Zuhlke L, Mayosi BM. Asymptomatic rheumatic heart disease
in South African schoolchildren: Implications for addressing chronic health conditions
through a school health service. S Afr Med J 2016;106(8):761-762. DOI:10.7196/SAMJ.2016.
v106i8.10756
11. Madeira G, Mocumbi AO, Mayosi BM. Advice to health professionals: Use of lignocaine as a diluent
to reduce the pain associated with the administration of benzathine penicillin G. S Afr Med J
2016;106(8):742. DOI:10.7196/SAMJ.2016.v106i8.10864
12. Engel ME, Haileamlak A, Zhlke L, et al. Prevalence of rheumatic heart disease in 4720
asymptomatic scholars from South Africa and Ethiopia. Heart 2015;101(17):1389-1394. DOI:10.1136/
heartjnl-2015-307444
13. Zuhlke L, Engel M, Lemmer C, et al. The natural history of latent rheumatic heart disease in a
5 year follow-up study: A prospective observational study. BMC Cardiovasc Disord 2016;16(1):46.
DOI:10.1186/s12872-016-0225-3
14. Zhlke L, Mayosi BM. Echocardiographic screening for subclinical rheumatic heart disease remains a
research tool pending studies of impact on prognosis. Curr Cardiol Rep 2013;15(3):343. DOI:10.1007/
s11886-012-0343-1
15. Duncan NA, Kronenberger WG, Hampton KC, et al. A validated measure of adherence to antibiotic
prophylaxis in children with sickle cell disease. Patient Prefer Adherence 2016;10:983-992.
DOI:10.2147/PPA.S103874
16. Owen EP, Leisegang F, Whitelaw A, et al. Complement component C5 and C6 mutation screening
indicated in meningococcal disease in South Africa. S Afr Med J 2012;102(6):525-527.
17. Zhlke L, Engel ME, Karthikeyan G, et al. Characteristics, complications, and gaps in evidence-based
interventions in rheumatic heart disease: The Global Rheumatic Heart Disease Registry (the REMEDY
study). Eur Heart J 2015;36(18):1115-1122. DOI:10.1093/eurheartj/ehu449
18. Watkins D, Zuhlke L, Engel M, et al. Seven key actions to eradicate rheumatic heart disease in Africa:
The Addis Ababa Communiqu. Cardiovasc J Afr 2016;27(3):184-187. DOI:10.5830/CVJA-2015-090
19. World Health Organization. Global Action Plan for the Control and Prevention of Noncommunicable
Disease 2013-2020. Geneva: WHO, 2013.
20. South African National Department of Health. National Guidelines on the Primary Prevention and
Prophylaxis of Rheumatic Fever and Rheumatic Heart Disease for Health Professionals at Primary
Level. Pretoria: NDoH, 1997.
21. Van Dam J, Musuku J, Zuhlke LJ, et al. An open-access, mobile compatible, electronic patient register
for rheumatic heart disease (eRegister) based on the World Heart Federations framework for patient
registers. Cardiovasc J Afr 2015;26(6):227-233. DOI:10.5830/CVJA-2015-058